The Next Generation Antibody Drug Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Next Generation Antibody Drug Market?
The market size for the next generation antibody drug has seen rapid growth in recent years. It is expected to increase from $14.26 billion in 2024 to $16.54 billion in 2025, with a compound annual growth rate (CAGR) of 16.0%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Next Generation Antibody Drug Industry?
The Next Generation Antibody Drug Global Market Report 2025 predicts that the market size of next generation antibody drugs will be $29.72 billion in 2029, growing at a compound annual growth rate of 15.8%.
Download Your Free Sample of the 2025 Next Generation Antibody Drug Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Next Generation Antibody Drug Market?
The key drivers in the next generation antibody drug market are:
• Rising demand for personalized medicine
• Expanding drug pipeline
• Increasing healthcare awareness
• Growing number of research collaborations
Global Market Segmentation: Identifying Major Next Generation Antibody Drug Industry Segments
The next generation antibody drug market covered in this report is segmented –
1) By Product Type: Monoclonal Antibodies, Bispecific Antibodies, Antibody-Drug Conjugates, Other Types
2) By Mechanism Of Action: Checkpoint Inhibitors, Immune Modulators, Receptor Blockers, Targeted Cytotoxic Agents, Neutralizing Antibodies
3) By Delivery Method: Intravenous (IV) Administration, Subcutaneous Administration, Intramuscular Administration, Oral Formulations, Transdermal Delivery Systems
4) By Application: Oncology, Autoimmune Diseases, Infectious Diseases, Other Applications
5) By End User: Hospitals, Research Institutes, Specialty Clinics, Other End Users
Pre-order the 2025 Next Generation Antibody Drug Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Next Generation Antibody Drug Market?
The key trends in the next generation antibody drug market are:
• Advancements in antibody-drug conjugates are shaping the future of the market.
• There is an emerging trend in technological developments in bispecific antibodies.
• Integration of next-generation sequencing is becoming a significant trend.
• Protein engineering advancements and gene therapy integration are emerging developments shaping the market.
Who Are the Top Competitors & Leading Players in the Next Generation Antibody Drug Market?
Major players in the next generation antibody drug market are:
• Pfizer Inc.
• F. Hoffmann-La Roche Ltd.
• Bristol-Myers Squibb Company
• AstraZeneca plc
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company Limited
• Gilead Sciences Inc.
• Amgen Inc.
• Boehringer Ingelheim International GmbH
• Regeneron Pharmaceuticals Inc.
• Biogen Inc.
• Kyowa Hakko Kirin Co. Ltd.
• Samsung Biologics Co. Ltd.
• WuXi Biologics Inc.
• Akeso Inc.
• Xencor Inc.
• ImmunoGen Inc.
• Philogen S.p.A.
• Telix Pharmaceuticals Limited
• Actinium Pharmaceuticals Inc.
Regional Dominance: Which Area Leads the Global Next Generation Antibody Drug Market?
North America was the largest region in the next generation antibody drug market in 2024
